1099:HKG
Sinopharm Group Co Ltd
HK$15,72
arrow_upward
+0,45%(+0,070) 1D
16 Okt., 16:08:14 GMT+8 · HKD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 1099...
Open
HK$15,79
High
HK$15,99
Low
HK$15,67
Mkt. cap
49,06 mjd
Avg. vol.
4,85 m
Volume
5,89 m
Dividend
5,03%
Quarterly dividend
HK$0,20
Ex-dividend date
23 Jun. 2026
P/E ratio
5,90
52-wk high
HK$22,34
52-wk low
HK$14,55
EPS
HK$2,67
Shares outstanding
1,19 mjd
No. of employees
90 k
Open
HK$15,79
High
HK$15,99
Low
HK$15,67
Mkt. cap
49,06 mjd
Avg. vol.
4,85 m
Volume
5,89 m
Dividend
5,03%
Quarterly dividend
HK$0,20
Ex-dividend date
23 Jun. 2026
P/E ratio
5,90
52-wk high
HK$22,34
52-wk low
HK$14,55
EPS
HK$2,67
Shares outstanding
1,19 mjd
No. of employees
90 k
News stories
From web sources and news partners
TradingView
·
4 uur gelede
BlackRock's Long Position In H Shares Of Sinopharm Reduces To 9.23% On Oct 13, HKEX Shows
ad-hoc-news.de
·
1 dag gelede
HKD 16.95 average target for Sinopharm stock from 14 ratings
Profile
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
About Sinopharm Group Co Ltd